NorthStar Medical Technologies Files New Drug Application with FDA
Northstar Press Release - March 20, 2013
NorthStar Medical Radioisotopes, LLC (NorthStar) announced that it has submitted a New Drug Application (NDA) with the Food and Drug Administration (FDA). The FDA has accepted the application for review. The submission is for NorthStar’s TechneGen™ Generator System, which will allow nuclear pharmacies to process radioisotopes for critical medical procedures using NorthStar’s natural, non-uranium based Molybdenum-99 (Mo99) as source material. Read more...
NorthStar Medical Radioisotopes Awarded $22.2 Million in Federal Funds
Northstar Press Release - November 15, 2012
NorthStar Medical Radioisotopes, LLC (NorthStar), today announced that it has been awarded $22.2 million in federal funding in a Phase 2 cooperative agreement through the National Nuclear Security Administration's (NNSA) Global Threat Reduction Initiative. Read more...
NorthStar Medical Technologies, Hendricks Commercial Properties Sign Agreement for Beloit Facility Development
Northstar Press Release - September 26, 2012
NorthStar Medical Technologies, LLC (NorthStar), today announced that it has signed an agreement with Hendricks Commercial Properties, LLC (HCP) to develop a state-of-the-art medical isotope production facility in the Gateway Business Park of Beloit, Wisconsin. Read more...
Wisconsin's NorthStar Medical Technologies Secures $5.2 Million in Additional Funding for Safe, Domestic Radioisotope Production
Northstar Press Release - September 5, 2012
NorthStar Medical Technologies, LLC (NorthStar), a manufacturer and distributor of domestically-produced radioisotopes for the nuclear medicine field, today announced the closing of a Series D preferred stock financing round totaling $5.2 million. Read more...
Wanted: Money for entrepreneurs
Wisconsin State Journal - May 22, 2012
Everybody loves the entrepreneur, the little guy or gal with the big idea who launches and expands a business. Politicians of every stripe correctly tout start-up companies as key to creating more jobs. Yet entrepreneurs can seem almost mythical during a challenging economy. Where and who are these creative risk-takers? Read more...
Race for isotope shows Wisconsin's strength
Milwaukee Journal-Sentinal - November 5, 2011
What does it say about a state's innovation-based economy when it boasts not one but two of the four U.S. companies racing to produce a medical isotope so essential that it's used in 50,000 clinical tests per day? Something reassuring, it can be hoped, especially if you believe Wisconsin's future depends in part on its ability to grow new companies from within. Read more...
Nuclear agency to share cost of developing Beloit plant
Milwaukee Journal-Sentinal - November 1, 2011
NorthStar Medical Radioisotopes LLC said Tuesday it has signed a $4.6 million agreement with the National Nuclear Security Administration that will help the Madison company develop architectural and site plans for a Beloit plant to produce medical isotopes. Read more...
NNSA Signs Cooperative Agreement to Produce Molybdenum-99 in the United States without the use of Highly Enriched Uranium
National Nuclear Security Administration (NNSA) - November 1, 2011
The National Nuclear Security Administration's (NNSA) Global Threat Reduction Initiative announced today the signing of a cooperative agreement with NorthStar Medical Radioisotopes, LLC, to further the development of accelerator-based technology to produce molybdenum-99 (Mo-99) in the United States. Read more...
NorthStar Medical Radioisotopes Receives Additional Funding Award for Medical Isotope Program
Northstar Press Release - November 1, 2011
NorthStar Medical Radioisotopes, LLC (NMR) has signed a follow on cooperative agreement totaling $4.6 million with the National Nuclear Security Administration's (NNSA) Global Threat Reduction Initiative for the company's medical isotope production program. Read more...
NorthStar Finds Way to Produce Medical Isotope Quickly, Safely
Milwaukee Journal-Sentinal - September 18, 2011
Production issues at several nuclear power plants outside the U.S. during the last few years and worries about nuclear proliferation prompted the federal government in 2009 to look for ways to make a critical medical isotope more safely and closer to home. Fortunately for NorthStar, its principals understood the situation and were already working on a solution. Read more...
NorthStar to Produce Mo-99 Isotope
The Business Journal - September 12, 2011
NorthStar Medical Radioisotopes LLC, a Madison nuclear medicine company, has signed a tentative agreement for its Beloit facility to process radioactive material into a key isotope used for medical procedures. Read more...
GE Hitachi Nuclear Energy and Exelon Announce the Potential Production of Critical Medical Isotope at Clinton Power Station
September 12, 2011
2011—To help address a shortage of molybdenum-99 (Mo-99), a medical isotope used in millions of medical procedures each year, GE Hitachi Nuclear Energy (GEH) and Exelon have joined to study the feasibility of producing Mo-99 at Clinton Power Station, a nuclear power plant in Clinton, Ill.. Read more...
NorthStar Medical Radioisotopes Named Winner of BioForward’s 2011 Emerging Company Showcase
September 8, 2011
NorthStar Medical Radioisotopes was among six Wisconsin bioscience companies to be selected as the winners of BioForward's 2011 Emerging Company Showcase. The showcase is part of the 2011 Bioscience Vision Summit, hosted by BioForward, the member-driven state association that is the voice of Wisconsin's bioscience industry. Read more...
BioForward Announces Winners of 2011 Bioscience Vision Summit's Emerging Company Showcase
MADISON, Wis. - August 11, 2011 --(BUSINESS WIRE)--
Six Wisconsin bioscience companies have been selected as the winners of BioForward’s 2011 Emerging Company Showcase. The showcase is part of the 2011 Bioscience Vision Summit, being held on Thursday, September 8th, at the Madison Marriott West in Madison, Wis. and hosted by BioForward, the member-driven state association that is the voice of Wisconsin’s bioscience industry. The Emerging Company Showcase is sponsored by the University of Wisconsin-Madison Office of Corporate Relations, WARF, and Exact Sciences.
Northstar Medical Radioisotopes, Madison, WI
NorthStar provides innovative solutions for material shortages in the nuclear medicine market that have plagued the industry and research. NorthStar’s main focus is to produce Technetium-99m, which is used in over 50,000 diagnostic tests daily. FDA approval is expected by year end. Read more...
High-tech firm picks Beloit for $194 million development
Beloit Daily News - June 22, 2011
NorthStar Medical Radioisotopes, LLC announced plans today to build the facility and occupy a 33-acre site adjacent to Gateway Boulevard. The company expects to break ground by mid-2012, with production beginning in 2013.The development is projected to create about 150 jobs by 2016. Read more...
Greater Beloit Economic Development Corporation Announces Plans for New NorthStar Medical Radioisotopes, LLC Production Facility
Greater BeloitWorks - June 22, 2011
Greater Beloit Economic Development Corporation (GBEDC) today announced plans for NorthStar Medical Radioisotopes, LLC (NorthStar) to locate a new 82,000 square foot production facility in Beloit. The $194 million dollar facility will create over 150 jobs by 2016. Read more...
Commerce Award Assists Rock County Job Growth
Wisconsin Economic Development Corporation - June 22, 2011
A newly-announced major economic development project in Rock County will benefit from significant state assistance. NorthStar Medical Radioisotopes reported its plans to create over 150 jobs at a new production facility in Beloit. Read more...
NorthStar Medical to build $194 million radioisotopes plant in Beloit
Wisconsin Technology Council - June 22, 2011
NorthStar Medical Radioisotopes LLC is planning to build a $194 million production plant in Beloit that could employ as many as 150 workers by 2016. Read more...
NorthStar Radiosotopes, LLC moving to Beloit, Wisconsin
Wisconsin BrokerNET - June 22, 2011
An announcement was made today by NorthStar Medical Radioisotopes, LLC (NorthStar) regarding their intentions to locate a 82,000 SF medical radioisotope production facility in the City of Beloit. Read more...
NorthStar medical firm to build plant in Beloit
Wisconsin State Journal - June 22, 2011
NorthStar Medical Radioisotopes, Madison, will build an 82,000-square-foot manufacturing plant in Beloit. The $194 million project will qualify for up to $14 million in state tax credits under a program that will be handled by the new Wisconsin Economic Development Corp. Read more...
City, state incentives helped land company
Beloit Daily News - June 22, 2011
To support NorthStar’s development in Beloit, both the City of Beloit and the Wisconsin Department of Commerce have offered the company an incentive package. If approved by the Beloit City Council at its July 5 meeting, the city plans to use tax incremental financing to fund a $50,000 grant to be used for training new employees, according to Andrew Janke, the executive director of the Greater Beloit Economic Development Corporation. Read more...
NorthStar Medical to build $194 million plant in Beloit
Milwaukee Journal Sentinal - June 22, 2011
NorthStar Medical Radioisotopes LLC is planning to build a $194 million production plant in Beloit that could employ as many as 150 people by 2016. NorthStar Medical hopes to break ground by mid-2012 and be making products for market by 2013, said Glenn Isensee, chief technology officer. Read more...
High tech jobs may be coming to Beloit
GazetteXtra.com - June 22, 2011
NorthStar Medical Radioisotopes, LLC plans to locate a new 82,000 square foot production facility in Beloit. Read more...
Hendricks Holdings makes Investment in NorthStar Medical Radioisotopes
NorthStar Press Release - April 7, 2011
NorthStar Medical Radioisotopes, LLC (NorthStar) announced it has received an investment from Hendricks Holdings of Beloit, WI. The investment will allow NorthStar to rapidly pursue introduction of new technologies and production methodologies in the nuclear medicine market for molybdenum-99 and other medically significant radioisotopes. Read more...
NorthStar Medical Radioisotopes signs agreement with Missouri University to supply Molybdenum-99
NorthStar Press Release - March 1, 2011
NorthStar Medical Radioisotopes, LLC (NorthStar) announced it has signed an agreement with the University of Missouri Research Reactor (MURR) to supply NorthStar with low specific activity molybdenum-99. Read more...